{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:17:03Z","timestamp":1777465023371,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.biomaterials.2011.01.061","type":"journal-article","created":{"date-parts":[[2011,2,13]],"date-time":"2011-02-13T06:40:25Z","timestamp":1297579225000},"page":"3627-3636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Han-Ning","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venugopal","family":"Rajanbabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Jer","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyh-Yih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2011.01.061_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.it.2005.11.005","article-title":"Triggering TLR signaling in vaccination","volume":"27","author":"van Duin","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-60761-585-9_3","article-title":"Nonclinical safety assessment of vaccines and adjuvants","volume":"626","author":"Wolf","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib3","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","article-title":"The global impact of vaccines containing aluminium adjuvants","volume":"20","author":"Clements","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib4","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","article-title":"Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle","volume":"124","author":"Gherardi","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib5","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/1381612043383971","article-title":"Membrane disrupting lytic peptides for cancer treatments","volume":"10","author":"Leuschner","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib6","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.vaccine.2006.03.072","article-title":"Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31","volume":"24","author":"Agger","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib7","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1016\/j.vaccine.2006.03.071","article-title":"IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses","volume":"24","author":"Schellack","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/dna.2007.0693","article-title":"The synthetic antimicrobial peptide KLKL5KLK enhances the protection and efficacy of the combined DNA vaccine against Mycobacterium tuberculosis","volume":"27","author":"Li","year":"2008","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nbt1288","article-title":"An anti-infective peptide that selectively modulates the innate immune response","volume":"25","author":"Scott","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib11","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1128\/JVI.79.18.11598-11606.2005","article-title":"Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells","volume":"79","author":"Van Compernolle","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib12","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.4049\/jimmunol.170.9.4708","article-title":"Retrocyclin, an antiretroviral theta-defensin, is a lectin","volume":"170","author":"Wang","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib13","series-title":"The Togaviridae and Flaviviridae","article-title":"Pathobiology of flavivirus","author":"Monath","year":"1990"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib14","series-title":"The Togaviruses","article-title":"Medical significance of Togavirus: an overview of disease caused by Togavirus in man and domestic and wild vertebrate animals","author":"Shope","year":"1980"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neulet.2007.04.071","article-title":"Japanese encephalitis virus infection decrease endogenous IL-10 production: correlation with microglial activation and neuronal death","volume":"420","author":"Swarup","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib16","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1128\/JVI.00291-08","article-title":"Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo","volume":"82","author":"Goncalvez","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib17","first-page":"103","article-title":"Review of accidents caused by incomplete inactivation of viruses","volume":"81","author":"Brown","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib18","first-page":"119","article-title":"Adverse reactions to Japanese encephalitis vaccine in travellers","volume":"32","author":"Nothdurft","year":"1996","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","article-title":"Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants","volume":"161","author":"Poland","year":"1990","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib21","first-page":"50","article-title":"Virus inactivation in the 1990s-and into the 21st century. Part 4, Culture media, biotechnology products, and vaccines","volume":"18","author":"Sober","year":"2003","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"10.1016\/j.biomaterials.2011.01.061_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11908-009-0006-6","article-title":"Japanese encephalitis: new vaccines","volume":"11","author":"Wilson","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/viro.1995.1479","article-title":"Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells","volume":"212","author":"Cardoso","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib24","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/jvi.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+ T cells","volume":"66","author":"Connors","year":"1992","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib25","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.peptides.2009.08.019","article-title":"Epinecidin-1 peptide induces apoptosis which enhances antitumor effects in human leukemia U937 cells","volume":"30","author":"Chen","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.peptides.2008.10.007","article-title":"Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells","volume":"30","author":"Lin","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/dna.2006.0564","article-title":"Gene expression and\u00a0localization of the epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its role in protecting fish against pathogenic infection","volume":"26","author":"Pan","year":"2007","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fsi.2009.10.001","article-title":"Inactivation of nervous necrosis virus infecting grouper (Epinephelus coioides) by epinecidin-1 and hepcidin 1-5 antimicrobial peptides, and downregulation of Mx2 and Mx3 gene expressions","volume":"28","author":"Wang","year":"2010","journal-title":"Fish Shellfish Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.vaccine.2003.10.011","article-title":"In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine","volume":"22","author":"Wu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib30","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1128\/JVI.73.12.10137-10145.1999","article-title":"Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines","volume":"73","author":"Chen","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jmv.1890440204","article-title":"Homologous and heterologous neutralizing antibody response after immunization with Japanese encephalitis vaccine among Taiwan children","volume":"44","author":"Ku","year":"1994","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1099\/vir.0.008045-0","article-title":"Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model","volume":"90","author":"Biswas","year":"2009","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jmv.21688","article-title":"Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice","volume":"82","author":"Biswas","year":"2010","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib34","first-page":"25","article-title":"Biological and clinical implications of interleukin-7 and lymphopoiesis","volume":"5","author":"Appasamy","year":"1999","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri888","article-title":"Viruses and interferon: a fight for supremacy","volume":"2","author":"Katze","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.biomaterials.2011.01.061_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virusres.2009.03.007","article-title":"Japanese encephalitis\u00a0virus NS2B-NS3 protease induces caspase 3 activation and mitochondria-mediated apoptosis in human medulloblastoma cells","volume":"143","author":"Yang","year":"2009","journal-title":"Virus Res"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib37","first-page":"1693s","article-title":"BCL-2 gene family and the regulation of programmed cell death","volume":"59","author":"Korsmeyer","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib38","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/jvi.66.4.2564-2569.1992","article-title":"Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle","volume":"66","author":"Pavlovic","year":"1992","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2011.01.061_bib39","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1111\/j.1460-9568.2000.01314.x","article-title":"Parkin expression in the adult mouse brain","volume":"12","author":"Stichel","year":"2000","journal-title":"Eur J Neurosci"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:27:30Z","timestamp":1758900450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961211001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":39,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0142961211001074"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.01.061","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.01.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}